India’s 3one4 Capital has closed its latest venture capital fund with INR4 billion ($57 million) in commitments and raised INR450 million for seed investment vehicle.
The VC fund – known as Continuum I – had a target of INR3.5 billion and reached a first close of INR1.5 billion in February. LPs include Emory Investment Management, which manages the Emory University...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.